title: What's new in invasive pulmonary aspergillosis in the critically ill.
authors.affiliation: 2nd Department of Critical Care Medicine, Attikon University Hospital, Athens, Greece.
authors.forename: Despoina
authors.initials: D
authors.lastname: Koulenti
authors.forename: Dirk
authors.initials: D
authors.lastname: Vogelaers
authors.forename: Stijn
authors.initials: S
authors.lastname: Blot
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D000941:Antigens / Q000097:blood; D015415:Biomarkers / Q000097:blood; D016638:Critical Illness; D042241:Early Diagnosis; D005690:Galactose / Q000031:analogs & derivatives; D006801:Humans; D016867:Immunocompromised Host; D007158:Immunologic Techniques; D015994:Incidence; D055744:Invasive Pulmonary Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D008351:Mannans / Q000276:immunology; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000453:epidemiology
chemical_list: D000935:Antifungal Agents; D000941:Antigens; D015415:Biomarkers; D008351:Mannans; C012990:galactomannan; D005690:Galactose